ALPHA CANCER THERAPY
Targeted conformal radiotherapy of disseminated cancers, using the alpha-particle emitting radionuclides astatine-211, bismuth-213 and actinium-225.
| Coordinator | GOETEBORGS UNIVERSITET |
| Grant period | 2012-04-01 - 2014-11-01 |
| Funding body | European Union |
| Call number | FP7-PEOPLE-2010-IEF |
| Grant number | 272348 |
| Identifier | G:(EU-Grant)272348 |